Glutamate and neurotrophic factors in neuronal plasticity and disease

MP Mattson - Annals of the New York Academy of Sciences, 2008 - Wiley Online Library
Glutamate's role as a neurotransmitter at synapses has been known for 40 years, but
glutamate has since been shown to regulate neurogenesis, neurite outgrowth …

[BUCH][B] A primer of drug action: A concise nontechnical guide to the actions, uses, and side effects of psychoactive drugs, revised and updated

RM Julien - 2013 - books.google.com
Since 1975, Robert Julien's A Primer of Drug Action has been the definitive guide to the
effects of psychoactive drugs on the brain and on behavior. Now fully updated, this popular …

D-serine added to antipsychotics for the treatment of schizophrenia

G Tsai, P Yang, LC Chung, N Lange, JT Coyle - Biological psychiatry, 1998 - Elsevier
Background: Hypofunction of N-methyl-D-aspartate (NMDA) subtype glutamate receptor has
been implicated in the pathophysiology of schizophrenia. D-serine is a full agonist of the …

[HTML][HTML] Development of allosteric modulators of GPCRs for treatment of CNS disorders

HH Nickols, PJ Conn - Neurobiology of disease, 2014 - Elsevier
The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a
promising new strategy with potential for develo** novel treatments for a variety of central …

Schizophrenia: from phenomenology to neurobiology

AHC Wong, HHM Van Tol - Neuroscience & Biobehavioral Reviews, 2003 - Elsevier
Schizophrenia is a common and debilitating illness, characterized by chronic psychotic
symptoms and psychosocial impairment that exact considerable human and economic …

Removing obstacles in neuroscience drug discovery: the future path for animal models

A Markou, C Chiamulera, MA Geyer… - …, 2009 - nature.com
Despite great advances in basic neuroscience knowledge, the improved understanding of
brain functioning has not yet led to the introduction of truly novel pharmacological …

Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia

A Becker, B Peters, H Schroeder, T Mann… - Progress in Neuro …, 2003 - Elsevier
It was investigated whether subchronic application of 30 mg/kg ketamine (Ket) induces
reliable changes in behaviour and parameters of dopaminergic, glutamatergic, and …

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

G Tsai, HY Lane, P Yang, MY Chong, N Lange - Biological psychiatry, 2004 - Elsevier
BACKGROUND: Hypofunction of N-methyl-D-aspartate glutamate receptor had been
implicated in the pathophysiology of schizophrenia. Treatment with D-serine or glycine …

The" two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

I Weiner - Psychopharmacology, 2003 - Springer
Rationale Latent inhibition (LI), namely, poorer performance on a learning task involving a
previously pre-exposed non-reinforced stimulus, is disrupted in the rat by the dopamine (DA) …

Schizophrenia and the mechanisms of conscious integration

G Tononi, GM Edelman - Brain Research Reviews, 2000 - Elsevier
This article considers the possibility that defective interactions among distributed brain areas
may underlie certain dysfunctions of conscious integration such as those seen in …